EVLA and Optimal Timing of Sclerotherapy

NCT04774939 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
350
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Turku University Hospital

Collaborators